13F Insight
DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Inflation hedgeYield
BCRX

BIOCRYST PHARMACEUTICALS INC

318 institutions still hold BIOCRYST PHARMACEUTICALS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 09058V103·Biological Products, (No Diagnostic Substances)·318 13F holders·last filed Mar 31, 2026
Market cap
—
▲ 2.9%
vs prior quarter
13F value held
$1.6B
46.0% inst. owned
of float
Holders
318
+44 QoQ
filers reporting
Activity
+69 / −49
+832 added · −722 reduced
this quarter
Concentration
13.55%
BlackRock, Inc. #1
top holder share
AI Holders Summary · Q1 2026

318 institutions reported BCRX in Q1 2026. BlackRock, Inc. leads at 13.5% of the visible book. +44 net new institutions vs prior quarter — accumulation reading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
BlackRock, Inc.
CIK 0002012383
$216M22.7M0.00%Q1 202602
RA CAPITAL MANAGEMENT, L.P.
CIK 0001346824
$151M15.8M1.60%Q1 202603
STATE STREET CORP
CIK 0000093751
$116M12.2M0.00%Q1 202604
DEERFIELD MANAGEMENT COMPANY, L.P.
CIK 0001009258
$112M14.3M1.43%Q4 202505
Vanguard Portfolio Management
CIK 0002100121
$107M11.2M0.01%Q1 202606
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$106M11.1M0.00%Q1 202607
TCG Crossover Management, LLC
CIK 0001839948
$105M11.0M3.00%Q1 202608
JANUS HENDERSON GROUP PLC
CIK 0001274173
$85M8.9M0.04%Q1 202609
PERCEPTIVE ADVISORS LLC
CIK 0001224962
$71M7.4M1.38%Q1 202610
Vestal Point Capital, LP
CIK 0001974915
$67M7.0M1.87%Q1 202611
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
$61M6.4M0.05%Q1 202612
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$55M5.8M0.00%Q1 202613
Kynam Capital Management, LP
CIK 0001907884
$54M5.7M3.34%Q1 202614
BANK OF AMERICA CORP /DE/
CIK 0000070858
$48M5.1M0.00%Q1 202615
Aberdeen Group plc
CIK 0001716774
$48M5.0M0.08%Q1 202616
UBS Group AG
CIK 0001610520
$47M4.9M0.01%Q1 202617
Frazier Life Sciences Management, L.P.
CIK 0001892134
$38M4.0M0.98%Q1 202618
Royalty Pharma Sub-Manager, LLC
CIK 0002081668
$37M3.8M21.19%Q1 202619
Nuveen, LLC
CIK 0001871926
$36M3.8M0.01%Q1 202620
TWO SIGMA ADVISERS, LP
CIK 0001478735
$32M4.1M0.06%Q4 2025
Page 1 of 16
298 more holders available. Log in →